Transmission of a 2009 H1N1 pandemic influenza virus occurs before fever is detected, in the ferret modelHuman MX2 is an interferon-induced post-entry inhibitor of HIV-1 infectionStructure of an avian influenza A virus NS1 protein effector domainContact transmission of influenza virus between ferrets imposes a looser bottleneck than respiratory droplet transmission allowing propagation of antiviral resistanceMutations in haemagglutinin that affect receptor binding and pH stability increase replication of a PR8 influenza virus with H5 HA in the upper respiratory tract of ferrets and may contribute to transmissibilityThe short stalk length of highly pathogenic avian influenza H5N1 virus neuraminidase limits transmission of pandemic H1N1 virus in ferretsA phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.Viral factors in influenza pandemic risk assessment.Cellular immune correlates of protection against symptomatic pandemic influenza.Infection of human airway epithelium by human and avian strains of influenza a virus.Low dose influenza virus challenge in the ferret leads to increased virus shedding and greater sensitivity to oseltamivir.Accumulation of human-adapting mutations during circulation of A(H1N1)pdm09 influenza virus in humans in the United Kingdom.One-way trip: influenza virus' adaptation to gallinaceous poultry may limit its pandemic potential.Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics.Generation of candidate human influenza vaccine strains in cell culture - rehearsing the European response to an H7N1 pandemic threatMutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium.Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential.Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.Variability in H9N2 haemagglutinin receptor-binding preference and the pH of fusionImmune Escape Variants of H9N2 Influenza Viruses Containing Deletions at the Hemagglutinin Receptor Binding Site Retain Fitness In Vivo and Display Enhanced Zoonotic CharacteristicsA single amino acid in the HA of pH1N1 2009 influenza virus affects cell tropism in human airway epithelium, but not transmission in ferrets.An influenza reassortant with polymerase of pH1N1 and NS gene of H3N2 influenza A virus is attenuated in vivo.Predominance of heterosubtypic IFN-γ-only-secreting effector memory T cells in pandemic H1N1 naive adults.Obesity and susceptibility to severe outcomes following respiratory viral infection.Avian Influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways.Fatal cases of influenza a in childhood.HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activationTransfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factorRIG-I detects viral genomic RNA during negative-strand RNA virus infection.Immune responses in pigs vaccinated with adjuvanted and non-adjuvanted A(H1N1)pdm/09 influenza vaccines used in human immunization programmes.Glycomic characterization of respiratory tract tissues of ferrets: implications for its use in influenza virus infection studiesAntiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry.The Functional Study of the N-Terminal Region of Influenza B Virus NucleoproteinNS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response.Antigenic mapping of an H9N2 avian influenza virus reveals two discrete antigenic sites and a novel mechanism of immune escape.Species difference in ANP32A underlies influenza A virus polymerase host restrictionInvestigation of influenza virus polymerase activity in pig cells.The effect of the PB2 mutation 627K on highly pathogenic H5N1 avian influenza virus is dependent on the virus lineage.Computational and molecular analysis of conserved influenza A virus RNA secondary structures involved in infectious virion productionPause on avian flu transmission research.
P50
Q21134081-A1C94365-3F1A-42AE-AE01-6E43887604C3Q24336824-6964C2F7-E765-43C9-ABB8-9E45557C7B35Q27650988-ACA0AC55-3B61-44CB-8CB1-7971B4F100C7Q28384431-69EFCA19-DCA6-483B-B6D3-56335965FA72Q28385604-7A114ECE-2FC7-45F5-956C-752FF3311CCEQ28390168-72FD8A8E-0657-4544-8E45-44E3EE83D202Q30228084-1D984CFF-B6D5-4A62-8BEE-4666D72D14BEQ30275435-E51B1FAC-5157-4C43-8309-7A17F9C90C8FQ30353819-127751B7-C5A7-4607-818C-95F0998124B2Q30355972-5F7B51BF-6541-4531-A882-42F5992FFA34Q30361125-C14164F9-3532-46DF-B5EB-7E9D377A1CDCQ30366662-17B1DD39-2104-44B2-8F94-E6C22348BAFCQ30370246-1588AC72-1091-4697-BECC-8F1950873A0DQ30376923-1D828A2D-9F21-4BDC-9EBA-BABDE59F19FBQ30376964-E1F51DAF-B832-4311-A474-BB56A34FA6E2Q30382671-A9123E03-0C84-420D-B018-D8CFA6456152Q30396667-2281A0E0-F29D-4A54-BBAF-6E8E5821E9B7Q30397718-A43DA56D-BADB-4D81-8ACD-AE70F138B655Q30400181-075A72BC-C3BE-456A-A1B8-0A8C3222A716Q30401640-50952530-0207-48CA-A822-C07BE46685C6Q30408155-A7FE00CD-CB42-49A9-849B-5AD80CF83525Q30412888-636513CB-B74C-479F-9C1B-110AAAB0839CQ30418993-EA5852B3-C569-47B7-930B-ADD268D54D30Q30427526-D849BD14-D942-476E-B131-AD2AB3E6CEEBQ33444633-8828D8BD-3342-48FB-8A85-95C06F972B7DQ33513974-A1C137B2-8739-464F-BF50-305DA1A8F4CCQ33865132-6AAC5792-0CCA-43ED-8DD5-86728548F50CQ34059183-E9D7CE04-2CE1-4DD8-BB72-2EEEA3B7B160Q34097840-024972F3-6885-41FC-9457-DFCA430F9D6BQ34199805-56ADBF2A-2444-4421-8B55-C9EE3E3628D5Q34317413-1F887634-8D04-460B-8092-38B738532F4EQ35605579-CB547522-6412-41C7-B8E4-A3107CF70339Q35773994-9D620965-7676-49D9-8436-E90213675512Q35784659-C8E2022E-7025-45FB-9A12-8C978E9FC3C6Q36438526-BC754473-6639-42AF-BBDA-D43951802DA8Q36456422-E5C43E84-D61C-4316-8D0D-693C4E456D1DQ36506769-FC0E7FAA-1934-4F55-BE99-854D8359810FQ37123100-41A4DCD0-F274-41B0-A551-797FA6281A2FQ37238003-8FBE06AA-CD2A-46B7-91EE-9098D742C963Q37265666-28B336AE-A5A8-40C2-A4D6-0C2D71D7AA54
P50
description
British virologist
@en
British virologist
@en-ca
British virologist
@en-gb
angol virológus
@hu
viroloog
@nl
viróloga británica
@es
عالمة فيروسات بريطانية
@ar
name
Wendy Barclay
@ast
Wendy Barclay
@de
Wendy Barclay
@en
Wendy Barclay
@es
Wendy Barclay
@hu
Wendy Barclay
@nl
Wendy Barclay
@ro
type
label
Wendy Barclay
@ast
Wendy Barclay
@de
Wendy Barclay
@en
Wendy Barclay
@es
Wendy Barclay
@hu
Wendy Barclay
@nl
Wendy Barclay
@ro
prefLabel
Wendy Barclay
@ast
Wendy Barclay
@de
Wendy Barclay
@en
Wendy Barclay
@es
Wendy Barclay
@hu
Wendy Barclay
@nl
Wendy Barclay
@ro
P101
P106
P1153
7005440974
P2002
wendybarclay11
P21
P213
0000 0001 2441 234X
P31
P345
P463
P496
0000-0002-3948-0895
P569
2000-01-01T00:00:00Z